Bioaffinity Technologies, Inc.
BIAF
Revenue
2.40M
▼-8.74k▼-0.3632%
3 Months ChangeAssets
6.66M
▼-1.39M▼-17.30%
3 Months ChangeLiabilities
3.22M
▲431.12k▲15.44%
3 Months ChangeFree Cash Flow
-2.39M
▼-826.01k▼-52.90%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-21
Form 8-K
ID: 0001493152-24-041721
2024-10-10
Form 8-K
ID: 0001493152-24-040679
2024-10-09
Form 8-K
ID: 0001493152-24-040539
2024-10-07
Form 8-K
ID: 0001493152-24-039644
2024-08-23
Form 8-K
ID: 0001493152-24-033762
2024-08-14
Form 10-Q
ID: 0001493152-24-031943
2024-08-05
Form 8-K
ID: 0001493152-24-030193
2024-07-09
Form 8-K
ID: 0001493152-24-026639
2024-06-05
Form 8-K
ID: 0001493152-24-022738
2024-05-16
Form 8-K
ID: 0001493152-24-020059